Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Crossman

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|December 3, 2014
Audit: time to review the cycleSimon Glew, Sangeetha Sornalingam, Timothy Crossman
The British Journal of Oral & Maxillofacial Surgery|December 20, 2015
Role of general practice in the diagnosis of oral cancerTimothy Crossman, Fiona Warburton, Michael A Richards, et al.
International Journal of Hematology|September 5, 2023
Safety, pharmacokinetics, and efficacy of belantamab mafodotin monotherapy in Japanese patients with relapsed or refractory multiple myeloma: DREAMM-11Shinsuke Iida, Kazutaka Sunami, Yuko Mishima, et al.
Therapeutic Advances in Hematology|September 18, 2024
Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasmsJustin Watts, Mark D Minden, Kimo Bachiashvili, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|December 3, 2014
Audit: time to review the cycleSimon Glew, Sangeetha Sornalingam, Timothy Crossman
The British Journal of Oral & Maxillofacial Surgery|December 20, 2015
Role of general practice in the diagnosis of oral cancerTimothy Crossman, Fiona Warburton, Michael A Richards, et al.
International Journal of Hematology|September 5, 2023
Safety, pharmacokinetics, and efficacy of belantamab mafodotin monotherapy in Japanese patients with relapsed or refractory multiple myeloma: DREAMM-11Shinsuke Iida, Kazutaka Sunami, Yuko Mishima, et al.
Therapeutic Advances in Hematology|September 18, 2024
Phase I/II study of the clinical activity and safety of GSK3326595 in patients with myeloid neoplasmsJustin Watts, Mark D Minden, Kimo Bachiashvili, et al.
Pageof 1